1472 results
TAVI outcomes in women with small annuli
18 May 2021 – From EuroPCR 2021
Watch this session presented by Thomas Modine, Nicole Karam and Sabine Bleiziffer to learn more about the latest studies regarding TAVI outcomes in women with small annuli, and to discover the results of self-expanding supra-annular TAVI compared to SAVR in this population.
Improving your patient's outcomes with the Edwards Benchmark program
18 May 2021 – From EuroPCR 2021
Watch this session presented by Hélène Eltchaninoff in order to understand the benefit of delivering a standardised care pathway to consistently achieve excellent outcomes, to improve access to high quality of care with safe early discharge for selected patients, in Europe, and to learn how the Edwards Benchmark...
Efficient TAVI in the context of expanding indications?
18 May 2021 – From EuroPCR 2021
Watch this session presented by Lars Sondergaard and Didier Tchetche in order to review latest data from the Evolut low-risk trial and the OptimizePro study, to learn more about latest TAVI patient pathway efficiency and economics evidence, and to discover how to translate these insights locally and enable you...
Next-generation TAVR device will enable lifetime management of aortic stenosis patients
18 May 2021 – From EuroPCR 2021
Watch this session presented by Michael Reardon in order to learn more about supra-annular leaflet functioning in a balloon expandable TAVR device that enables commissural alignment, about 3D single-piece aortic valve design and how it contributes to improved TAVR durability, about the ADAPT tissue science and its proven resistance...
New, novel Navitor TAVI valve with active paravalvular leak-sealing technology
18 May 2021 – From EuroPCR 2021
Watch this session presented by Lars Sondergaard to learn about the latest TAVI active PVL-sealing technology, to understand the clinical evidence with the active PVL-sealing technology, and to discuss the value that the new, novel Navitor valve brings in today's TAVI market.
View the recording of this EuroPCR 2021 Session...
Treating bicuspid patients, sizing algorithms
18 May 2021 – From EuroPCR 2021
Watch this session presented by Chris Malkin, Sonia Petronio and Amit Segev to learn more about treating bicuspid patients and sizing algorithms.
Timing and indication for PCI in TAVI patients with coronary disease
18 May 2021 – From EuroPCR 2021
Watch this session presented by Nicolas Dumonteil, Simon Redwood and Marco Barbanti to learn more about the indications for PCI in TAVI patients with coronary disease, to know more about the latest evidence from the ACTIVATION Trial and the RE-ACCESS Study, and to discover some interesting tips...
The uncompromised hemodynamics of the ALLEGRA transfemoral TAVI system in native and small annuli
18 May 2021 – From EuroPCR 2021
Watch this session presented by Raul Moreno and Dave Smith in order to learn about the hemodynamic performance of the ALLEGRA TAVI system, to share the experience of European centres through challenging ALLEGRA cases, and to focus on the outcome of the ALLEGRA TAVI system in small annuli...
Complete 2-year follow-up from the Evolut low risk trial
18 May 2021 – From EuroPCR 2021
This session was originally presented during EuroPCR 2021.
PCR's Got Talent - Valvular Interventions
18 May 2021 – From EuroPCR 2021
Thanks to the abstracts of this session, find out more about heterotopic caval valve implantation preprocedural assessment, patient-specific computer simulation to predict long-term outcomes after TAVI, and much more!
A low-risk patient with a bicuspid type 0 aortic stenosis
18 May 2021 – From EuroPCR 2021
How would you treat an 82-year-old male patient presented with dyspnoea NYHA III who is also found to have IPMN? View this session to analyze the authors' decision!
Challenging TAVI cases
18 May 2021 – From EuroPCR 2021
In this session, look at TAVR complications, study how to find a way to deliver an aortic valve prosthesis, and think about how to treat a failing tissue AVR in a fit 60 year-old doctor.
EuroPCR 2021 - Innovations in TAVI
18 May 2021 – From EuroPCR 2021
In this session, find out more about an innovative active sealing cuff providing a new strategy to mitigate PVL, post-implantation CT scans to print patient-specific 3D models, transcatheter antiembolic filter, and much more!
Introducing Navitor: a new TAVI solution
18 May 2021 – From EuroPCR 2021
Watch this session presented by Helge Möllmann, Lars Sondergaard, Maurizio Taramasso, Ganesh Manoharan and Dave Smith in order to discuss how to minimise resources needed for your TAVI procedure without compromising safety and efficacy, to demonstrate how to simplify your TAVI procedure, and to examine considerations for lifetime management of your...
Planning for a long run: life-time management of bioprosthetic valve implantation
18 May 2021 – From EuroPCR 2021
Watch this session presented by Stephan Windecker, Anna Sonia Petronio, Mohamed Abdel-Wahab, Lars Sondergaard and Hendrik Treede in order to learn about life-time management strategies of aortic stenosis patients, to discuss evolving multifactorial aspects that influence the choice of aortic stenosis patient treatment, and to explore THV...
TAVI in a patient with coronary artery disease - Session with LIVE demonstration
18 May 2021 – From EuroPCR 2021
Watch this session if you want to discuss the available data for treating coronary artery disease in patients undergoing TAVI and to understand the role of FFR/IFR in coronary artery disease assessment prior to TAVI.
This session was originally presented during EuroPCR 2021.
PCI in a patient with prior TAVI - Session with LIVE demonstration
18 May 2021 – From EuroPCR 2021
Watch this session if you want to discuss the available data for treating coronary artery disease in patients undergoing TAVI and to understand the role of FFR/IFR in coronary artery disease assessment prior to TAVI.
This session was originally presented during EuroPCR 2021.
PCR STATEMENT on the 2-year clinical outcomes from the Evolut low risk trial
18 May 2021
Transcatheter aortic valve implantation (TAVI) offers an effective, less invasive therapeutic alternative to surgical aortic valve replacement in patients with symptomatic, severe aortic stenosis. Although TAVI is demonstrated to be superior to medical therapy or surgery in patients who are at prohibitive or high risk for...
TAVI-in-Bioprostheses - never a dull moment
12 May 2021 – From EuroPCR 2021
In this session, observe degenerated biologic surgical valve fracturing after TAVI implantation, analyze aortic valve-in-valve on a complex vascular anatomy, learn more about aortic and mitral valves dysfunction after surgical replacement, and even more!
Left heart suffering after successful TAVI
12 May 2021 – From EuroPCR 2021
In this session, analyze a rare case of cardiogenic shock after TAVR, get prepared in case of Takotsubo cardiomyopathy after transcatheter aortic valve-in-valve replacement, get hints for troubleshooting in treating left-sided obstructions, find out more about transfemoral TAVI and mitral clipping for prevention of a SAM-phenomenon, and more!
